Accretion Nutraveda Share Price Today

Accretion Nutraveda H1FY27 Results: Net profit up 98.6% to ₹4.73 crore

Net profit rose 98.6% YoY to ₹4.73 crore in H1FY27. Revenue from operations surged 109.35% to ₹29.44 crore. EBITDA margin contracted to 21.27% from 23.69% due to higher raw material costs. 100% of ₹24.77 crore IPO proceeds utilized for capacity and working capital.

Accretion Nutraveda shareholders approve MOA changes, borrowing limits

Shareholders approved five special resolutions via postal ballot concluded on October 10, 2026. All resolutions passed with 100% majority; borrowing limits and MOA changes included. MOA altered to include nutraceuticals, pharma, and agricultural integration objects. Resolution on subsidiary loans saw low participation with only 3,000 valid votes cast.

Accretion Nutraveda seeks ₹500 crore borrowing limit via postal ballot

Accretion Nutraveda seeks approval to raise borrowing limits to ₹500 crore. Shareholders to vote on altering MOA to expand business objects. E-voting period runs from September 10 to October 9, 2026. Board proposes ₹100 crore limit for loans to subsidiaries and investments.

Accretion Nutraveda board approves MOA alteration, borrowing limits

Accretion Nutraveda board approved MOA alterations to expand business scope. Borrowing limits increased under Section 180(1)(c) of Companies Act. Shareholder approval required via postal ballot process. New powers include investing in securities and agricultural activities.

Accretion Nutraveda AGM resolutions pass with unanimous shareholder support

Accretion Nutraveda shareholders unanimously approved all 10 resolutions at its 5th AGM. Standalone financial statements for FY26 were adopted with 5.32 million votes in favor. Two new independent directors, Chand Kanabar and Grishma Shewale, were appointed. Remuneration revisions for six key executives received 100% shareholder support.

Accretion Nutraveda to seek approval for director appointments, pay hikes at AGM

Accretion Nutraveda Limited's 5th AGM on August 27, 2026, focuses on governance updates, including the appointment of two independent directors and remuneration revisions for six key executives. Shareholders will also adopt FY26 financials showing ₹3,360.31 lakh revenue.